CliffBio
small molecule

ATROPINE

ATROPINE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameATROPINE
Active ingredientATROPINE
StrengthEQ 2MG SULFATE/0.7ML
Dosage formSOLUTION
RouteINTRAMUSCULAR
ModalitySmall molecule
FDA approvalJanuary 1987
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ATROPINE patent cliff — loss of exclusivity — | CliffBio